indazole protecting group - An Overview
Within this review, we compile The existing improvement of indazole derivatives as kinase inhibitors and their software as anticancer brokers up to now 5 years.Especially, compound 187 exerted important entire body weight reduction in diet-induced obese F344 rats and was anticipated to be a novel antiobesity agent dependant on MCHR1 antagonistic ac